ArticleInternational journal of environmental research and public health2022
Perceived Stigma of Patients Undergoing Treatment with Cannabis-Based Medicinal Products.
Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.
- Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024Guideline
- Anticipated Stigma in Nursing: A Concept Analysis Informed by Cannabis Use Disclosure.Journal of advanced nursing · 2026Review
- The use of cannabis for medical reasons in the UK: Prescriptions, sources, products, and high-risk use.Psychological medicine · 2026Article
- Combined extraction and spray-freeze-drying of Cannabis sativa Flos provides stable lyophilizate particles of cannabinoids.Journal of cannabis research · 2026Article
- From farm to bedside: Potential of medical cannabis in global health.Complementary therapies in medicine · 2025Review
- Healthcare Professionals' Perceptions About Medical Cannabis in Greece: A Qualitative Study.Journal of market access & health policy · 2025Article
- 'In the weeds': navigating the complex concerns, challenges and choices associated with medicinal cannabis consumption for endometriosis.Reproduction & fertility · 2025Article
- Marketing Management and Policymaking for Medical Cannabis: Overcoming Barriers and Shaping Strategies.Cannabis (Albuquerque, N.M.) · 2025Article
- Patterns of Use and Patient-Reported Effects of Cannabinoids in People With PD: A Nationwide Survey.Parkinson's disease · 2025Article
- Understanding Cannabis-Related Information Needs: An Analysis of Inquiries to the National Cancer Institute's Cancer Information Service.Cannabis and cannabinoid research · 2024Article
- Illicit Cannabis Use to Self-Treat Chronic Health Conditions in the United Kingdom: Cross-Sectional Study.JMIR public health and surveillance · 2024Article
- Awareness of medical cannabis regulations among UK police officers - a cross-sectional study.The Medico-legal journal · 2024Article
- Cannabis use in a Canadian long-term care facility: a case study.BMC geriatrics · 2024Article
- Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer's Disease.Current issues in molecular biology · 2024Review
- The role of stigma in cannabis use disclosure: an exploratory study.Harm reduction journal · 2024Article
- Awareness and interest in cannabis use for cancer management among cancer survivors.Cancer medicine · 2024Article
- Shifting focus: the need for early intervention and safer alternatives in autism spectrum disorder treatment.Trends in psychiatry and psychotherapy · 2024Article
- Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson's disease: A French survey.Clinical parkinsonism & related disorders · 2024Article
- Effects of historical inequity and institutional power on cannabis research: Moving toward equity and inclusion.PNAS nexus · 2023Article
- Cannabis as a Source of Approved Drugs: A New Look at an Old Problem.Molecules (Basel, Switzerland) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cannabis-based medicinal products (CBMPs) are prescribed with increasing frequency. This study aimed to investigate the perceived stigma attached to patients prescribed CBMPs in the UK to establish its prevalence. A qualitative survey was developed by an expert multidisciplinary group and data were collected via Qualtrics. In total, 2319 patients on CBMP therapy were invited to take part in this study. 450 (19.4%) participants completed the questionnaire. In total, 81.3% (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.